News
Weight loss drugs like Ozempic may prevent dementia: study
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia. That’s a potential game changer for the more than 6 million Americans diagnosed each year and the 100,000 who die from the memory-robbing disease annually.
MedPage Today on MSN2d
Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of DiabetesThis combination "provided weight loss in the highest range of efficacy observed with existing weight loss interventions," ...
Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...
News-Medical.Net on MSN21h
Cagrilintide and semaglutide together drive record weight loss in global trialA 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...
Wegovy, which is a prescription medicine is indicated to help manage weight and lower the risk of serious heart-related ...
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback